Our Prostate Cancer community was happy when Bayer and Algeta announced an Early/Expanded Access Program for Alpharedin. However we notice that, as of today, there is only one clinical trial site that is currently open and taking any new patients. However, this site is limited to only 2 men per month and their waiting list almost goes into the next calendar year!

Men who are experiencing excruciating pain could be receiving pain relief and the opportunity for extended life with early access to Alpharadin.

We ask that Bayer and Algeta put their Early/Expanded Access Program as announced into action, today. Open the sites that have been listed, add more sites and remove the caps from the sites.

Please join Malecare in contacting the following individuals and ask;

“Please make Alpharedin available today to men with advanced stage prostate cancer.

Send an email today and let them know we need Alpharadin NOW.

1- Clinical-trials-contact@bayerhealthcare.com
2- Mike Booth; Algeta Communications & Corporate Affairs; ir@algeta.com
3- Mark Swallow; Algeta International Media Inquiries; Citigate Dewe Rogerson; mark.swallow@citigatedr.co.uk

Joel T Nowak, M.A., M.S.W.